Major pharma acquisition complete

0
2039
LinkedIn
Facebook
Twitter
Whatsapp
Telegram
Copy link

Khaitan & Co acted as domestic legal counsel and Troutman Sanders as international counsel to Fosun Pharma, which on 3 October completed its acquisition of a majority stake in Gland Pharma.

The acquisition is the largest overseas acquisition by a Chinese pharmaceutical company and the largest acquisition of an Indian company by a Chinese buyer.

When the deal was initially announced, in July 2016, the Chinese pharmaceutical company was to acquire all the shares of Gland Pharma owned by US private equity investor KKR and shares of its other shareholders. Cyril Amarchand Mangaldas (CAM) was domestic legal counsel and Simpson Thacher & Bartlett was international counsel to KKR and Gland Pharma.

You must be a subscribersubscribersubscribersubscriber to read this content, please subscribesubscribesubscribesubscribe today.

For group subscribers, please click here to access.
Interested in group subscription? Please contact us.

你需要登录去解锁本文内容。欢迎注册账号。如果想阅读月刊所有文章,欢迎成为我们的订阅会员成为我们的订阅会员

已有集团订阅,可点击此处继续浏览。
如对集团订阅感兴趣,请联络我们

LinkedIn
Facebook
Twitter
Whatsapp
Telegram
Copy link